Remdesivir eases covid-19 symptoms in monkeys in 12 hours, small preliminary study shows

Canada News News

Remdesivir eases covid-19 symptoms in monkeys in 12 hours, small preliminary study shows
Canada Latest News,Canada Headlines
  • 📰 Newsweek
  • ⏱ Reading Time:
  • 35 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 52%

There is currently no specific treatment for COVID-19.

shows the global spread of the newas of early April 16. More than 2.1 million people have been afflicted, over 530,000 of whom have recovered and over 140,000 of whom have died.

The study being conducted in animals presented both strengths and weaknesses, said Preston. An animal model shows more than anBut Preston said that effects in animals won't necessarily translate to humans. Preston also argued the study's small sample size was another limitation, so extrapolation the results in a larger sample of subjects"needs to be done with caution."," Preston continued.

treatment should be started, as symptoms do not usually develop until a few days after exposure to the virus. "Both of these options would require rapid identification of cases which would require scaled up community diagnostic screening to be in place."

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Newsweek /  🏆 468. in US

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

How the CARES Act Eases Retirement Account Rules During COVID-19How the CARES Act Eases Retirement Account Rules During COVID-19The Coronavirus Aid, Relief, and Economic Security Act (CARES Act) aims to help Americans cope with the unprecedented financial fallout from the COVID-19 outbreak. Among its provisions, the CARES Act makes it easier to withdraw funds saved in certain tax-advantaged retirement accounts like 401(k)s and traditional Individual Retirement Accounts (IRAs). These temporary changes eliminate tax penalties […]
Read more »

A desperate scramble as COVID-19 families vie for access to plasma therapyA desperate scramble as COVID-19 families vie for access to plasma therapyEven as efforts ramp up to collect blood plasma from the first survivors of coronavirus, chances of procuring treatment appear to depend on geography, social-media savvy, and the willingness of physicians.
Read more »

A New Frontier for Self-Love—And Sex Toys—in the Time of COVID-19A New Frontier for Self-Love—And Sex Toys—in the Time of COVID-19With an uptick in conversation around female desire and a boom in female-led sex tech companies, one Vogue writer explores self-love in the time of COVID-19.
Read more »

Why an analyst bullish on Gilead says antiviral drug ‘won’t solve’ COVID-19Why an analyst bullish on Gilead says antiviral drug ‘won’t solve’ COVID-19“Did remdesivir just ‘solve’ COVID? No,” says Umer Raffat, an analyst at Evercore ISI.
Read more »

Gupta: Federal guidance, Singapore-developed tech needed to fight COVID-19Gupta: Federal guidance, Singapore-developed tech needed to fight COVID-19“What we need is creative thinking,' VinGuptaMD says of U.S. issues with testing for COVID-19. 'There are ways to get around these bottlenecks, we just have to have federal guidance.”
Read more »



Render Time: 2025-03-01 20:34:24